Latest Evido Health News & Updates

See the latest news and media coverage for Evido. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Evido Health (Evido)

AI-driven chronic liver disease detection software

evido.health
Founded year
2021
Company type
Private company
Number of employees
15–50

Last updated

Latest news about Evido Health (Evido)

In short: Evido advanced its LiverPRO technology through clinical validation, key leadership appointments, and a strategic distribution agreement with Roche.

Company announcements

  • Evido

    Evido publishes research letter on LiverPRO

    It shows 71% fewer unnecessary referrals and 29% lower cost per detected case versus FIB-4 for liver fibrosis detection in SLD patients.

  • Evido

    Evido highlights LiverPRO outperforming FIB-4

    Studies at EASL SLDSummit2026 show LiverPRO improves fibrosis risk stratification, identifying more cases and reducing misses.

  • Evido

    Evido highlights LiverPRO in EASL guidance

    LiverPRO is recommended as a scalable first-line non-invasive test for liver fibrosis in steatotic liver disease using routine blood data.

  • Evido

    Evido highlights LiverPRO in EASL abstracts

    Abstracts confirm LiverPRO outperforms FIB-4 in detecting early liver fibrosis. Multiple studies validate its superior performance in risk stratification and validation.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Evido

Track Evido and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.